Key result
Endocardial ventricular tachycardia ablation can be safely performed by passing through an atrial flow regulator device lumen without requiring an additional transseptal puncture.
Why the study?
Novel interventional therapies for heart failure patients, such as the atrial flow regulator, are emerging.
Can endocardial ventricular tachycardia ablation be performed safely by passing through an atrial flow regulator device lumen?
Can endocardial ventricular tachycardia ablation be performed safely by passing through an atrial flow regulator device lumen?
Transseptal access for VT ablation can be safely achieved through the lumen of an existing atrial flow regulator device, avoiding the need for a new transseptal puncture.
May facilitate VT ablation via existing AFR; hypothesis-generating and requires prospective validation before adoption.
Novel interventional therapies for heart failure patients are emerging like atrial flow regulator (AFR). Our case showed that endocardial ventricular tachycardia (VT) ablation could be performed safely by passing through the AFR device lumen without additional transseptal puncture in these patients.
No takes yet. Share an insight, caveat, or question.
Dural et al. (2020) studied this question. Endocardial ventricular tachycardia ablation can be safely performed by passing through an atrial flow regulator device lumen without requiring an additional transseptal puncture.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: